Xylem Inc <XYL.N>: Deutsche Bank Raises Target Price to $151 From $149
XYL•Related News
Processa Pharmaceuticals, Inc. Announces Acquisition Of Vidya Therapeutics, Inc. And Approximately $200 Million Concurrent Private Placement To Advance Btk Inhibitor, Vt-7208, In Multiple Disease Areas
PCSA•
Global-e to report Q2 results, host earnings call
GLBE•
Aon posts Q2 2026 earnings presentation slides
AON•
Castellana Properties, Acciona Energia launch 2,000 kW EV charging hub at El Faro mall in Spain
XLRE•
Tronox names Keith Schwarz to board, appoints him to audit committee
TROX•